• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常与异常生物自组装:来自人类溶菌酶及其淀粉样变变体研究的见解

Normal and aberrant biological self-assembly: Insights from studies of human lysozyme and its amyloidogenic variants.

作者信息

Dumoulin Mireille, Kumita Janet R, Dobson Christopher M

机构信息

Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.

出版信息

Acc Chem Res. 2006 Sep;39(9):603-10. doi: 10.1021/ar050070g.

DOI:10.1021/ar050070g
PMID:16981676
Abstract

Studies of lysozyme have played a major role over several decades in defining the general principles underlying protein structure, folding, and stability. Following the discovery some 10 years ago that two mutational variants of lysozyme are associated with systemic amyloidosis, these studies have been extended to investigate the mechanism of amyloid fibril formation. This Account describes our present knowledge of lysozyme folding and misfolding, and how the latter can give rise to amyloid disease. It also discusses the significance of these studies for our general understanding of normal and aberrant protein folding in the context of human health and disease.

摘要

几十年来,溶菌酶研究在确定蛋白质结构、折叠和稳定性的一般原理方面发挥了重要作用。大约10年前发现溶菌酶的两种突变变体与系统性淀粉样变性有关,之后这些研究扩展到对淀粉样纤维形成机制的研究。本综述介绍了我们目前对溶菌酶折叠和错误折叠的认识,以及后者如何导致淀粉样疾病。它还讨论了这些研究对于我们在人类健康和疾病背景下对正常和异常蛋白质折叠的总体理解的意义。

相似文献

1
Normal and aberrant biological self-assembly: Insights from studies of human lysozyme and its amyloidogenic variants.正常与异常生物自组装:来自人类溶菌酶及其淀粉样变变体研究的见解
Acc Chem Res. 2006 Sep;39(9):603-10. doi: 10.1021/ar050070g.
2
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.淀粉样纤维形成背后的人溶菌酶变体的不稳定性、解折叠和聚集。
Nature. 1997 Feb 27;385(6619):787-93. doi: 10.1038/385787a0.
3
Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants.人溶菌酶折叠的机制研究及其疾病相关变体中淀粉样生成行为的起源。
Biochemistry. 1999 May 18;38(20):6419-27. doi: 10.1021/bi983037t.
4
Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants.野生型人溶菌酶及其疾病相关突变变体的淀粉样纤维形成与种子化
J Struct Biol. 2000 Jun;130(2-3):339-51. doi: 10.1006/jsbi.2000.4264.
5
Lysozyme: a paradigmatic molecule for the investigation of protein structure, function and misfolding.溶菌酶:用于研究蛋白质结构、功能及错误折叠的典型分子。
Clin Chim Acta. 2005 Jul 24;357(2):168-72. doi: 10.1016/j.cccn.2005.03.022.
6
Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion.溶菌酶淀粉样变性通过特定的切口和片段化加速,但通过完整蛋白质结合和转化减速。
J Mol Biol. 2007 Feb 23;366(3):1029-44. doi: 10.1016/j.jmb.2006.11.084. Epub 2006 Dec 2.
7
Equine lysozyme: the molecular basis of folding, self-assembly and innate amyloid toxicity.马溶菌酶:折叠、自组装及先天性淀粉样毒性的分子基础。
FEBS Lett. 2007 Jun 12;581(14):2587-92. doi: 10.1016/j.febslet.2007.05.023. Epub 2007 May 21.
8
Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure.利用静水压力由人溶菌酶及其疾病相关变体形成淀粉样聚集体。
FASEB J. 2004 Jul;18(10):1099-101. doi: 10.1096/fj.03-1072fje. Epub 2004 May 20.
9
Tea catechins induce the conversion of preformed lysozyme amyloid fibrils to amorphous aggregates.茶儿茶素诱导预先形成的溶菌酶原纤维转化为无定形聚集体。
J Agric Food Chem. 2009 Dec 9;57(23):11391-6. doi: 10.1021/jf902664f.
10
Effect of the structure of the denatured state of lysozyme on the aggregation reaction at the early stages of folding from the reduced form.溶菌酶变性态结构对其从还原态折叠早期阶段聚集反应的影响。
J Mol Biol. 2005 Mar 18;347(1):159-68. doi: 10.1016/j.jmb.2005.01.022. Epub 2005 Jan 21.

引用本文的文献

1
Amyloid Forming Human Lysozyme Intermediates are Stabilized by Non-Native Amide-π Interactions.形成淀粉样蛋白的人溶菌酶中间体通过非天然酰胺-π相互作用得以稳定。
Adv Sci (Weinh). 2025 Sep;12(34):e03957. doi: 10.1002/advs.202503957. Epub 2025 Jun 25.
2
Detection of an Intermediate in the Unfolding Process of the N-Terminal Domain of TDP-43.TDP-43 N端结构域展开过程中一种中间体的检测
ACS Omega. 2025 Feb 5;10(6):5616-5633. doi: 10.1021/acsomega.4c08617. eCollection 2025 Feb 18.
3
Cryo-EM structure of a lysozyme-derived amyloid fibril from hereditary amyloidosis.
遗传性淀粉样变性中溶菌酶衍生的淀粉样纤维的冷冻电镜结构。
Nat Commun. 2024 Nov 7;15(1):9648. doi: 10.1038/s41467-024-54091-7.
4
Blood ACE Phenotyping for Personalized Medicine: Revelation of Patients with Conformationally Altered ACE.用于个性化医疗的血液血管紧张素转换酶表型分析:构象改变的血管紧张素转换酶患者的揭示
Biomedicines. 2023 Feb 13;11(2):534. doi: 10.3390/biomedicines11020534.
5
Food protein-derived amyloids do not accelerate amyloid β aggregation.食物蛋白源淀粉样肽不会促进淀粉样β聚集。
Sci Rep. 2023 Jan 31;13(1):985. doi: 10.1038/s41598-023-28147-5.
6
Molecular Dynamics of Lysozyme Amyloid Polymorphs Studied by Incoherent Neutron Scattering.通过非相干中子散射研究溶菌酶淀粉样多晶型物的分子动力学
Front Mol Biosci. 2022 Jan 17;8:812096. doi: 10.3389/fmolb.2021.812096. eCollection 2021.
7
The In Vitro Anti-amyloidogenic Activity of the Mediterranean Red Seaweed .地中海红藻的体外抗淀粉样蛋白生成活性
Pharmaceuticals (Basel). 2020 Aug 7;13(8):185. doi: 10.3390/ph13080185.
8
Reflections on professor Sir Christopher M. Dobson (1949-2019).对克里斯托弗·M·多布森爵士教授(1949 - 2019)的缅怀
Biophys Rev. 2020 Feb;12(1):13-18. doi: 10.1007/s12551-020-00612-9. Epub 2020 Jan 24.
9
Causative Links between Protein Aggregation and Oxidative Stress: A Review.蛋白聚集与氧化应激之间的因果关系:综述。
Int J Mol Sci. 2019 Aug 9;20(16):3896. doi: 10.3390/ijms20163896.
10
Catechol-Containing Hydroxylated Biomimetic 4-Thiaflavanes as Inhibitors of Amyloid Aggregation.含儿茶酚的羟基化仿生4-硫杂黄酮作为淀粉样蛋白聚集抑制剂
Biomimetics (Basel). 2017 May 9;2(2):6. doi: 10.3390/biomimetics2020006.